van Hedel Hubertus J A, Meyer-Heim Andreas, Rüsch-Bohtz Christina
a Rehabilitation Center Affoltern am Albis, University Children's Hospital Zurich , Affoltern am Albis , Zurich , Switzerland.
b Children's Research Center, University Children's Hospital Zurich , Affoltern am Albis , Zurich , Switzerland , and.
Dev Neurorehabil. 2016 Dec;19(6):410-415. doi: 10.3109/17518423.2015.1017661. Epub 2015 Apr 2.
Robot-assisted gait training (RAGT) can complement conventional therapies in children with cerebral palsy. We investigated changes in walking-related outcomes between children with different Gross Motor Function Classification System (GMFCS) levels and the dose-response relationship.
Data from 67 children (3.9-19.9 years) with GMFCS levels II-IV were evaluated retrospectively. Every child received RAGT with the Lokomat complementing a multidisciplinary rehabilitation program. Changes in various walking-related outcomes were assessed.
Walking-related outcomes did not improve differently between GMFCS level groups. Significant within-group improvements were mainly observed in children with GMFCS level IV. A dose-response relationship was present for children with GMFCS levels III and IV.
Our results indicated that, although children with a GMFCS level IV walked less during an average Lokomat session, they experienced significant improvements in walking-related outcomes. Further, training dose correlated with changes in walking-related outcomes. However, between-group differences in changes in walking-related outcomes were not significant.
机器人辅助步态训练(RAGT)可辅助脑瘫患儿的传统治疗。我们研究了不同粗大运动功能分类系统(GMFCS)水平的儿童在步行相关结局方面的变化以及剂量反应关系。
回顾性评估67例GMFCS水平为II-IV级的儿童(3.9 - 19.9岁)的数据。每个儿童均接受了Lokomat辅助多学科康复计划的RAGT治疗。评估了各种步行相关结局的变化。
GMFCS水平组间步行相关结局的改善无差异。组内显著改善主要见于GMFCS水平IV级的儿童。GMFCS水平III级和IV级的儿童存在剂量反应关系。
我们的结果表明,尽管GMFCS水平IV级的儿童在平均Lokomat训练过程中步行较少,但他们在步行相关结局方面有显著改善。此外,训练剂量与步行相关结局的变化相关。然而,步行相关结局变化的组间差异不显著。